Home > Trxade Group Inc. MEDS > Page 6

Tag: Trxade Group Inc. MEDS

TuesdayJun 16, 2020 9:42 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Appoints Experienced Healthcare Executive as President of Its Emerging Telemedicine Platform

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, recently announced that Ashton Maaraba is joining the Company as President of Bonum Health, Trxade Group’s telemedicine practice. According to the update, Maaraba brings over 20 years of experience in developing and directing strategic national sales, marketing, and operating initiatives in ever-changing, dynamic environments. Maaraba most recently served as the President of AshHealth, a healthcare market advisory firm located in Rochester, New York, where he spearheaded all facets of the business including market research, data analysis, financial development, business management and operations. “I am pleased to welcome Ashton…

Continue Reading

ThursdayJun 04, 2020 12:13 pm

Trxade Group Inc.’s (NASDAQ: MEDS) Pharmaceutical Marketplace Continues Profitable Expansion

Revenues for Q1 2020 up 46% year over year Gross profit of 75% shows viability of business model Close to 12,000 independent pharmacies now using online marketplace Stellar results recently reported by Trxade Group Inc. (NASDAQ: MEDS) are an indication that, increasingly, independent pharmacies, drug distributors and manufacturers are turning to the company’s web-based purchasing platform. At $2.2 million, revenues for Q1 2020 were up 46% year over year, with gross profit coming in at an extraordinary 74.4%. Now that more than 11,900 pharmacies are using the marketplace, Trxade seems set to fulfil its mission of signing most of the…

Continue Reading

WednesdayJun 03, 2020 12:38 pm

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Plans to Present at the June 2020 Virtual Investor Summit

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the June 2020 Virtual Investor Summit slated to take place June 9-12, 2020. According to the update, Trxade Group management is scheduled to present at 10:20 AM ET (7:20 AM PT) on Tuesday, June 9, 2020, and will host virtual one-on-one investor meetings throughout the event. Conference participation is by invitation only and registration is mandatory. Please contact your conference representative for more information or to schedule a virtual one-on-one meeting. To view the full press release, visit http://ibn.fm/T97q7 About Trxade…

Continue Reading

MondayJun 01, 2020 1:57 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing Premium Medical Teleconferences

Trxade Group (NASDAQ: MEDS), through its virtual healthcare subsidiary Bonum Health, provides telehealth services and prescription ordering via teleconferences that are conducted using smart devices. A recent article discussing the company reads, “The service provides subscribers with three premium medical teleconferencing visits through Bonum Health and prescription delivery through the company’s DelivMeds same day/mail-order pharmaceuticals service each month under the standard membership rate. . . . ‘With the seasonal flu outbreaks and the current coronavirus surge, patients are quick to brush off common symptoms, including cough, fever and body aches, as signs of a common cold; Telemedicine removes the barrier…

Continue Reading

ThursdayMay 21, 2020 11:39 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing COVID-19 Antibody Testing for Commercial Property Firm in Atlanta

Trxade Group (NASDAQ: MEDS) and its wholly owned subsidiary, Integra Pharma Solutions, were recently featured in a CoStar.com article titled ‘Lee & Associates Atlanta to Reopen Office Monday, Offer Coronavirus Antibody Testing’. The article reports that commercial property firm Lee & Associates Atlanta will be one of the first Atlanta-based firms to reopen. The firm is working with Saidcard and Integra Pharma Solutions to ensure its employees will be tested for the COVID-19 antibodies. These antibodies “show if you had a previous infection with the virus,” according to the Centers for Disease Control and Prevention (“CDC”). The CDC also stated…

Continue Reading

ThursdayMay 14, 2020 11:18 am

Trxade Group Inc. (NASDAQ: MEDS) Anticipates Successful Year Despite Pandemic, Building on 2019 Growth

Trxade Group Inc.’s technologically nimble health care platform and network help community-based pharmaceuticals meet the challenges of providing medications and medical consultation at lowering costs with efficiency and operational transparency The company’s year-end financial statement for 2019 shows revenues grew by nearly double over the previous year, and company officials expect to continue building on their success for 2020 As the current novel coronavirus pandemic drives quarantine-like social distancing policies, Trxade’s telehealth services make it easier for patients to access licensed medical professionals from virtually anywhere via personal technology for consultation The company’s ‘Bonum Health Hub’ will include free prescription…

Continue Reading

TuesdayMay 05, 2020 11:40 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report

Trxade Group Inc. (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We reiterate our Buy rating and $12 Price Target on MEDS following Q1 results that beat expectations. As the only estimate on the Street, we note that revenue, EBITDA and EPS were each ahead of our forecast. MEDS added 305 new pharmacy registrations which was in line with our forecast of 300. We were pleased also with the “same-store” growth of pharmacy prescription volume which was up 14% y/y and drove the upside to our model. Results were…

Continue Reading

MondayMay 04, 2020 1:04 pm

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Releases Q1 2020 Financial Results

Trxade Group, Inc. (NASDAQ: MEDS), an integrated telehealth, drug procurement, delivery and online healthcare marketplace, today reported its financial results for the first quarter ended March 31, 2020. Among the highlights, Trxade reported a 46% increase in Q1 2020 revenues to $2.2 million and 44% increase in net income to $0.2 million. “We demonstrated outstanding performance in the first quarter as we reported 46% growth in revenues and exceeded expectations on metrics despite COVID-19,” Suren Ajjarapu, chairman and CEO of Trxade Group, said in the news release. “Our diversified growth strategies are driving strong growth across all subsidiaries, including new…

Continue Reading

ThursdayApr 30, 2020 1:35 pm

QualityStocksNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integral Role in Efforts to Combat COVID-19 Featured in NetworkNewsAudio Podcast

Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, was featured in an exclusive NetworkNewsWire (“NNW”) audio podcast, via NNW’s audio press release solutions suite. The podcast contains NNW editorial coverage titled, “Medical Supply Companies Take on Crucial Role in Combatting Coronavirus” (http://ibn.fm/moaKe). Among other companies providing different critical elements in combating COVID-19, the editorial features Trxade and its role in delivering products and facilitating services to combat the virus’ spread locally. According to the editorial, “Integral to the efforts of over ten thousand pharmacies to procure and deliver essential supplies, Trxade Group Inc. (NASDAQ: MEDS)…

Continue Reading

ThursdayApr 30, 2020 11:23 am

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report

Trxade Group (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We are initiating coverage of Trxade with a Buy rating and Price Target of $12. MEDS’ primary offering is a web-based platform connecting large suppliers of branded and generic drugs with retail and independent pharmacies. The platform offers full price transparency, comparing the prices and availability across a variety of suppliers. Its latest offering is a direct-to-consumer application equipped with telemedicine visits which includes home delivery of medications. MEDS nearly doubled revenue in 2019 and we model the company…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

512.354.7000

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .